Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium
Conditions
Interventions
Intervention1: Arm-1Kalingadhy thailam
route of administration-oral
only at morning empty stomach
: trial drugs will be given only on menstrual period (3days) for 3 menstrual cycles
Dose
first day-15m
Sponsors
Central Council for Research in Siddha
Eligibility
Inclusion criteria
Inclusion criteria: 1 Trial participants who are at the age group of 18-35 years 2 Menstrual pain for more than 3 consecutive regular menstrual cycle without pelvic organ pathology 3 Complaints of primary dysmenorrhea from menarche or shortly after (6â??24 months) menarche. 4 Regular menstrual cycle of 24 to 32 days 5 Severe dysmenorrhea with 8-12 score using WaLLID tool
Exclusion criteria
Exclusion criteria: 1 Study participants who have pelvic inflammatory diseases 2 Irregular menstrual cycle 3 Secondary dysmenorrhea associated with ovarian cyst, endometriosis and fibroid (excluded clinically and radio logically) 4 Pain abdomen associated with excessive BPV 5 Having oral contraceptive pills and IUCD (Intrauterine contraceptive pills) 6 Who are under the treatment of hormonal therapy 7 who are pregnant/planning to pregnant, Lactating mother
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measures will be evaluating and comparing the efficacy of kalingadhy thailam and Inchi choornam in reducing pain among women with Dhoora soolai (Primary Dysmennorhea) by using WaLLID tool Timepoint: Baseline and 3rd day of every month of intervention and follow up totally 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Measuring the status of hormones before and after the administration of trial drugs. Measuring safety of the trial drug kalingadhy thailam Timepoint: Baseline After 3 months after 6 months | — |
Countries
India
Contacts
Public ContactDrPSathiyarajeswaran
Siddha Central Research Institute
Outcome results
None listed